“novartis” Archives

in
Entry Author Date Location
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech 06/02/20 Seattle
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs 05/08/20 National
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation 05/06/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer 04/20/20 National
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
UroGen Gets FDA Nod for Low-Grade Upper Tract Urothelial Cancer Drug 04/15/20 New York
Blackstone Pays Alnylam $1B to Grab a Stake in RNAi Drug Inclisiran 04/13/20 Boston
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch 03/26/20 New York
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing 03/24/20 National
Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data 03/09/20 Boston
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected 02/24/20 Detroit Ann Arbor
Page 2 of 27 « previous page · next page »